"By focusing our R&D operations in these centers, we are building the world's premier biopharmaceutical R&D enterprise," says Mikael Dolsten, president of BioTherapeutics Research & Development, in a statement. "This new structure puts Pfizer in the best position to conduct cutting-edge research within and beyond our own laboratories and to deliver a portfolio of high-impact medicines to patients."
As part of the consolidation, Pfizer will move a number of functions from Collegeville, PA.; Pearl River, NY; and St. Louis to other locations and will discontinue R&D operations in Princeton; Chazy, Rouses Point and Plattsburgh, NY; Sanford and Research Triangle Park, NC; and Gosport, Slough/Taplow, UK. In addition, Pfizer will consolidate R&D functions from its New London, CT site to its nearby research facility in Groton.
As a result of these changes, Pfizer said it will cut its global R&D square footage by 35%. R&D activities will now be conducted at five main sites and nine specialized units around the world as compared with 20 currently.
In an article in the Star-Ledger, Dolsten says that New Jersey will continue to be an important area for Pfizer. "But when it comes to research and development, we have decided to exit our presence." Dolsten says. "We're trying to create a structure that will be efficient and focused on fewer geographies."
When the merger between Pfizer and Wyeth, which was based in Madison, NJ, was announced in January, Pfizer said it intended to reduce its global workforce by approximately 10%, or roughly 8,000 jobs.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
